Effects of cyclohexanone analogues of curcumin on growth, apoptosis and NF-κB activity in PC-3 human prostate cancer cells

被引:28
作者
Wei, Xingchuan [2 ]
Du, Zhi-Yun [3 ]
Cui, Xiao-Xing [4 ]
Verano, Michael [4 ]
Mo, Rong Qing [3 ]
Tang, Zhi Kai [3 ]
Conney, Allan H. [3 ,4 ]
Zheng, Xi [3 ,4 ]
Zhang, Kun [1 ,3 ]
机构
[1] Guangdong Univ Technol, Coll Light Ind & Chem Engn, Lab Nat Med Chem & Green Chem, Higher Educ Mega Ctr, Guangzhou 510006, Guangdong, Peoples R China
[2] Guangzhou Univ, Dept Chem & Chem Engn, Guangzhou 510006, Guangdong, Peoples R China
[3] Guangdong Univ Technol, Allan H Conney Lab Anticanc Res, Guangzhou 510006, Guangdong, Peoples R China
[4] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Chem Biol, Susan Lehman Cullman Lab Canc Res, Piscataway, NJ 08854 USA
关键词
curcumin; analogues; cyclohexanone; prostate cancer; apoptosis; PANCREATIC-CANCER; DOWN-REGULATION; IN-VITRO; IMMUNODEFICIENT MICE; INDEPENDENT PATHWAY; TUMOR-GROWTH; INHIBITION; CARCINOMA; SUPPRESSION; KINASE;
D O I
10.3892/ol.2012.710
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Curcumin is a non-nutritive yellow pigment found in the spice turmeric, which is derived from the rhizome of the plant Curcuma longa Linn. Six cyclohexanone analogues of curcumin (A(1)-A(6)) were investigated for their effects on growth and apoptosis in PC-3 human prostate cancer cells. The ability of these compounds to inhibit NF-kappa B activity in PC-3 cells was also determined. Five out of the six curcumin analogues (A(2)-A(6)) had stronger inhibitory effects compared to curcumin on the growth of cultured PC-3 cells. Compounds A(2)-A(6) also had stronger stimulatory effects on apoptosis in PC-3 cells than curcumin, and these curcumin analogues more potently inhibited NF-kappa B activity than curcumin. The inhibitory effects of these compounds on NF-kappa B activity correlated with their effects on growth inhibition and apoptosis stimulation in PC-3 cells. The results of the present study provide a rationale for in vivo studies with A(2)-A(6) using suitable animal models of prostate cancer.
引用
收藏
页码:279 / 284
页数:6
相关论文
共 46 条
  • [1] Molecular targets of dietary agents for prevention and therapy of cancer
    Aggarwal, BB
    Shishodia, S
    [J]. BIOCHEMICAL PHARMACOLOGY, 2006, 71 (10) : 1397 - 1421
  • [2] Nuclear factor-κ-B:: The enemy within
    Aggarwal, BB
    [J]. CANCER CELL, 2004, 6 (03) : 203 - 208
  • [3] Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets
    Aggarwal, Bharat B.
    Sung, Bokyung
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2009, 30 (02) : 85 - 94
  • [4] Curcumin and cancer: An "old-age" disease with an "age-old" solution
    Anand, Preetha
    Sundaram, Chitra
    Jhurani, Sonia
    Kunnumakkara, Ajaikumar B.
    Aggarwal, Bharat B.
    [J]. CANCER LETTERS, 2008, 267 (01) : 133 - 164
  • [5] Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl
    Anto, RJ
    Mukhopadhyay, A
    Denning, K
    Aggarwal, BB
    [J]. CARCINOGENESIS, 2002, 23 (01) : 143 - 150
  • [6] Role of NF-κB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death
    Arlt, A
    Gehrz, A
    Müerköster, S
    Vorndamm, J
    Kruse, ML
    Fölsch, UR
    Schäfer, H
    [J]. ONCOGENE, 2003, 22 (21) : 3243 - 3251
  • [7] Possible Benefits of Curcumin Regimen in Combination With Taxane Chemotherapy for Hormone-Refractory Prostate Cancer Treatment
    Cabrespine-Faugeras, Aurelie
    Bayet-Robert, Mathilde
    Bay, Jacques-Olivier
    Chollet, Philippe
    Barthomeuf, Chantal
    [J]. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2010, 62 (02): : 148 - 153
  • [8] Curcumin inhibits connective tissue growth factor gene expression in activated hepatic stellate cells in vitro by blocking NF-κB and ERK signalling
    Chen, A.
    Zheng, S.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2008, 153 (03) : 557 - 567
  • [9] Cheng AL, 2001, ANTICANCER RES, V21, P2895
  • [10] Phase II trial of curcumin in patients with advanced pancreatic cancer
    Dhillon, Navneet
    Aggarwal, Bharat B.
    Newman, Robert A.
    Wolff, Robert A.
    Kunnumakkara, Ajaikumar B.
    Abbruzzese, James L.
    Ng, Chaan S.
    Badmaev, Vladimir
    Kurzrock, Razelle
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (14) : 4491 - 4499